Federated Hermes, Inc. Organon & Co. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Federated Hermes, Inc. holds 72,508 shares of OGN stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,508

Previous 74,013 2.03%

Holding current value

$1.08 Million

Previous $1.53 Million 9.46%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$18.65 - $23.03 $28,068 - $34,660	-1,505 Reduced 2.03%	72,508 $1.39 Million
Q2 2024 Aug 08, 2024	BUY	$17.45 - $21.96 $1.29 Million - $1.63 Million	74,008 Added 1480160.0%	74,013 $1.53 Million
Q4 2023 Jan 31, 2024	SELL	$10.95 - $17.32 $3,602 - $5,698	-329 Reduced 98.5%	5 $0
Q3 2023 Nov 13, 2023	SELL	$16.59 - $23.77 $31,587 - $45,258	-1,904 Reduced 85.08%	334 $5,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $32,643 - $41,723	1,694 Added 311.4%	2,238 $46,000
Q1 2023 May 08, 2023	BUY	$21.42 - $32.08 $11,009 - $16,489	514 Added 1713.33%	544 $12,000
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $4,988 - $6,122	-214 Reduced 87.7%	30 $0
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $7,137 - $10,446	-305 Reduced 55.56%	244 $7,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $385,650 - $473,840	-12,181 Reduced 95.69%	549 $19,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $115,892 - $149,804	3,806 Added 42.65%	12,730 $446,000
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $222,479 - $288,128	7,760 Added 666.67%	8,924 $272,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $127,832 - $159,132	-4,465 Reduced 79.32%	1,164 $39,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $160,145 - $213,902	5,629 New	5,629 $170,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Organon & Co. Transaction History